An oral cholera vaccine in the prevention and/or treatment of inflammatory bowel disease.

PLoS One · 2023 · PMC10461820 · PMID 37639428

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

close to significancep-value = 0.054so close (0.05 < p ≤ 0.1)

WC-rBS 5 also exhibited anti‐inflammatory effects, showing a decreased DAI score at 3.11 ± 0.26, close to significance (p-value = 0.054) in comparison to the DSS + PBS control group DAI at 4.00 ± 0.30 ( Fig 2C ).

also in 514 other papers

highly significantno p-value reported

Both preventive and curative administration of WC-rBS induced highly significant improvement in disease outcome and reduced colonic epithelial damage.

also in 29,987 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.